Therapeutic Asset Ratings

178 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
DICLOFENAC Lung Cancer	Emory University	P2	CCC (53)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4) Bladder Adenocarcinoma	Emory University	P2	CCC (53)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4) Bladder Squamous Cell Carcinoma	Emory University	P2	CCC (53)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4) Bladder Urachal Adenocarcinoma	Emory University	P2	CCC (53)
Epirubicin Bladder Adenocarcinoma	Emory University	P2	CCC (53)
Epirubicin Bladder Squamous Cell Carcinoma	Emory University	P2	CCC (53)
Epirubicin Urachal Adenocarcinoma	Emory University	P2	CCC (53)
FUROSEMIDE Prostate Carcinoma	Emory University	P2	CCC (53)
Iberdomide Smoldering Plasma Cell Myeloma	Emory University	P2	CCC (53)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Cutaneous Melanoma	Emory University	P2	CCC (53)
Inno-206 Lymphoproliferative Disorder	Emory University	P2	CCC (53)
L-Leucine Major Depressive Disorder	Emory University	P2	CCC (53)
LYSINE Major Depressive Disorder	Emory University	P2	CCC (53)
Niraparib Colorectal Carcinoma	Emory University	P2	CCC (53)
Niraparib Microsatellite Stable	Emory University	P2	CCC (53)
Niraparib RAS Wild Type	Emory University	P2	CCC (53)
Obinutuzumab CCND1 Positive	Emory University	P2	CCC (53)
Obinutuzumab Lymphoproliferative Syndrome	Emory University	P2	CCC (53)
PANITUMUMAB Microsatellite Stable	Emory University	P2	CCC (53)
Pembrolizumab Bladder Adenocarcinoma	Emory University	P2	CCC (53)
Pembrolizumab Bladder Squamous Cell Carcinoma	Emory University	P2	CCC (53)
Pembrolizumab Bladder Urachal Adenocarcinoma	Emory University	P2	CCC (53)
PREDNISONE TABLETS Lymphoproliferative Disorder	Emory University	P2	CCC (53)
PROPRANOLOL Bladder Transitional Cell Carcinoma	Emory University	P2	CCC (53)
PROPRANOLOL Renal Pelvis Urothelial Carcinoma	Emory University	P2	CCC (53)

Showing 76 to 100 of 178 assets

PreviousPage 4 of 8Next